Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 06, 2023 4:52pm
RE:RE:RE:Progenacare is now listing revyve on their website
KNE have an history of being overly optimistic when providing the investment community with 'target dates' to achieve milestones. Will see how it goes with revyve production, Q1 or Q2, the
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 03, 2023 6:40pm
RE:RE:Progenacare is now listing revyve on their website
Yeah, everyone here knows that a dope like you would know it will be Q2 when the company says Q1.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 02, 2023 1:54pm
RE:Progenacare is now listing revyve on their website
Yup, this is another positive. Finally some product visibility. Agree with you about the Q2 comment :)
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 02, 2023 1:52pm
RE:New Press Release - Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve(TM) Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
News seems to be well received by the market, volume is 7X higher on the alternatives exchanges. Let's see how maufacturing goes in Q1/Q2 if 2024. GLTA
(201)
•••
RoyMax123
X
View Profile
View Bullboard History
Post by
RoyMax123
on Nov 02, 2023 11:59am
Progenacare is now listing revyve on their website
https://www.progenacare.com/product/revyve/ And full production scale-up in Q1 (let say Q2 to be safe)
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 02, 2023 11:49am
New Press Release - Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve(TM) Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
Name change reinforces a fresh start for chronic wounds with a triple threat approach WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today announces the...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 25, 2023 7:45am
New Press Release - Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum
Company to unveil new Antimicrobial Wound Gel brand developed with ProgenaCare Global WINNIPEG, Manitoba, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it will be unveiling the new brand for its coactiv...
read article.
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Post by
KevinOleary
on Oct 14, 2023 12:33am
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Oct 10, 2023 10:06pm
RE:RE:RE:RE:RE:RE:RE:News required to move price upwards
You are my shining star kevinoleary! Thanks for your very useful post. You're the type of person we all need on a forum. Now, take your pills and go to bed. Good night.
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Oct 10, 2023 6:31pm
RE:RE:RE:RE:RE:RE:News required to move price upwards
1. "Well, if the plant is not ready to produce Coactiv+ as we speak then it is a very poorly execute process. " No, blindness is not the problem; you're just plain stupid. You try to
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Oct 10, 2023 4:21pm
RE:RE:RE:RE:RE:News required to move price upwards
Thanks RoyMax123 for sharing the info...I must have been blind not to see the video and the (very nice) photo of the Coactiv+ product. I was waiting for a press release regarding the production of the
...more
(201)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Oct 10, 2023 1:27pm
RE:RE:RE:RE:News required to move price upwards
And what surprise me is they expect to clean up the balance sheet and have some cash left with the sale of the animal health business, which is more than I expected
(201)
•••
RoyMax123
X
View Profile
View Bullboard History
Comment by
RoyMax123
on Oct 10, 2023 1:15pm
RE:RE:RE:News required to move price upwards
Frank, You have some answers here... https://www.facebook.com/watch/?v=292568703569665 DispersineB Clinical trial not started but near Acne Trial they are still working with university of Miami and
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Oct 09, 2023 12:01pm
RE:RE:News required to move price upwards
Well, if the plant is not ready to produce Coactiv+ as we speak then it is a very poorly execute process. The plant should have been up and ready to produce as soon as the FDA approval was granted
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >